Wolverine Trading, LLC Dbv Technologies S.A. Call Options Transaction History

Wolverine Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$1.39 - $5.58 $15,984 - $64,170	-11,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.71 - $5.92 $54,165 - $68,080	11,500 New	11,500 $55,000
Q2 2021 Aug 06, 2021	SELL	$5.32 - $6.53 $61,712 - $75,748	-11,600 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.75 - $6.57 $31,900 - $76,212	11,600 New	11,600 $62,000
Q3 2020 Nov 13, 2020	SELL	$1.58 - $4.77 $21,488 - $64,871	-13,600 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$3.74 - $6.28 $11,968 - $20,096	3,200 Added 30.77%	13,600 $63,000
Q1 2020 May 11, 2020	BUY	$2.33 - $12.98 $24,232 - $134,992	10,400 New	10,400 $42,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $88.3M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.